TrialGPT: Revolutionizing Clinical Trial Matching with AI

Researchers from the National Institutes of Health (NIH) have unveiled **TrialGPT**, an AI-powered tool designed to enhance the efficiency and effectiveness of matching patients with clinical trials. Developed using large language models, **TrialGPT** processes patient medical and demographic information to identify eligible clinical trials from ClinicalTrials.gov, providing annotated lists ranked by relevance. Encouragingly, TrialGPT can assess patient eligibility with an accuracy nearly on par with human clinicians. Moreover, a pilot study demonstrated that clinicians using TrialGPT spent 40% less time screening patients. This **technological innovation** promises to streamline clinical trial enrollment, potentially accelerating the progress of medical research by freeing clinicians to focus on tasks requiring human expertise. The study, showcasing promising results, was co-authored by collaborators from several prestigious institutions, and the research team has been awarded for further real-world assessments to ensure the model's effectiveness and fairness in clinical settings.